tivdakhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / Sitemap: | ||
Meta Tags
| Title | Tivdak® (tisotumab vedotin-tftv) | For Healthcare |
| Description | A Spark of Discover Tivdak® (tisotumab vedotin-tftv) for injection 40 mg. See full prescribing information, including BOXED WARNING for OCULAR TOXICITY, on official HCP |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 13.107.213.51 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tivdakhcp.com Valuation
|
US$6,321,274
Last updated: 2023-05-11 18:33:08
tivdakhcp.com has Semrush global rank of 1,674,394. tivdakhcp.com has an estimated worth of US$ 6,321,274, based on its estimated Ads revenue. tivdakhcp.com receives approximately 729,378 unique visitors each day. Its web server is located in United States, with IP address 13.107.213.51. According to SiteAdvisor, tivdakhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,321,274 |
| Daily Ads Revenue | US$5,836 |
| Monthly Ads Revenue | US$175,051 |
| Yearly Ads Revenue | US$2,100,608 |
| Daily Unique Visitors | 48,626 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tivdakhcp.com. | A | 298 | IP: 13.107.213.51 |
| tivdakhcp.com. | A | 298 | IP: 13.107.246.51 |
| tivdakhcp.com. | NS | 86400 | NS Record: ns4-06.azure-dns.info. |
| tivdakhcp.com. | NS | 86400 | NS Record: ns1-06.azure-dns.com. |
| tivdakhcp.com. | NS | 86400 | NS Record: ns2-06.azure-dns.net. |
| tivdakhcp.com. | NS | 86400 | NS Record: ns3-06.azure-dns.org. |
| tivdakhcp.com. | TXT | 3600 | TXT Record: d08wtfb9xytjh446s9sk1p0jkzr3fj45 |
HtmlToTextCheckTime:2023-05-11 18:33:08
| INDICATION: TIVDAK® is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. This indication is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. This site is intended for US healthcare providers only Prescribing Information Indication Important Safety Information Request a Representative For Patients This site is intended for US healthcare providers only Menu Close About Tivdak Mechanism of Action Study Overview Efficacy Response Rates Additional Data Safety Eye Care Prior to Infusion During and After Infusion Ongoing Eye Care Dosing Dosing and Administration Dosage Modification Resources Support Request a Representative Seagen Secure ® Text Reminders Request a Representative For Patients A Spark of Change See what’s |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 0 Location: https://tivdakhcp.com/ X-Azure-Ref: 0ENaMYQAAAAB5Xa+kIAI1R6EZHHVTVBzUQ0hHRURHRTE2MTgAZmIwNWJiYzUtZjQyOC00MDlmLTkzOGItYTc2M2QwNDc1NTlh Date: Thu, 11 Nov 2021 08:36:32 GMT HTTP/2 301 content-length: 0 location: https://www.tivdakhcp.com/ x-azure-ref: 0ENaMYQAAAACsa924bR4eQrvgQ9CILWCTQ0hHRURHRTE2MDgAZmIwNWJiYzUtZjQyOC00MDlmLTkzOGItYTc2M2QwNDc1NTlh date: Thu, 11 Nov 2021 08:36:31 GMT HTTP/2 200 content-length: 26738 content-type: text/html last-modified: Mon, 01 Nov 2021 15:55:40 GMT accept-ranges: bytes etag: "1d7cf38eb174e72" server: Kestrel x-cache: TCP_MISS x-azure-ref-originshield: 0EdaMYQAAAADCr06jEVjuRY49/DgEzrNVRVdSMzBFREdFMDUxNgBmYjA1YmJjNS1mNDI4LTQwOWYtOTM4Yi1hNzYzZDA0NzU1OWE= x-azure-ref: 0ENaMYQAAAADyeoVL//lyQ474HUr01TcyQ0hHRURHRTE2MTQAZmIwNWJiYzUtZjQyOC00MDlmLTkzOGItYTc2M2QwNDc1NTlh date: Thu, 11 Nov 2021 08:36:33 GMT |
tivdakhcp.com Whois Information
Domain Name: TIVDAKHCP.COM Registry Domain ID: 2605429616_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-05-10T18:36:14Z Creation Date: 2021-04-15T19:08:15Z Registry Expiry Date: 2022-04-15T19:08:15Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1-06.AZURE-DNS.COM Name Server: NS2-06.AZURE-DNS.NET Name Server: NS3-06.AZURE-DNS.ORG Name Server: NS4-06.AZURE-DNS.INFO DNSSEC: unsigned >>> Last update of whois database: 2021-11-11T07:52:21Z <<< |